Read the new issue from Health Affairs
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌


Problems viewing this email?

View Message In Browser
<[link removed]>

Dear John,

The August issue of Health Affairs was just released, featuring articles
on prescription drug price competition, the effects of OxyContin
marketing, the targeting of hospital COVID-19 relief funds, the effects
of a nurse home visiting program, and more.

Read The Issue
<[link removed]>


Prescription Drugs

Sean Dickson and coauthors analyze the effect on prices
<[link removed]>,
net of rebates, for all instances when a new brand-name pharmaceutical
is introduced that competes with an existing therapy. Between 2011 and
2019, this type of competition "was associated with a 4.2 percent
decrease in annual net price growth and resulted in net prices that were
6.8 percent lower, on average, than net prices before competition."

Annabelle Fowler and coauthors track the prevalence and characteristics
of authorized generics
<[link removed]>:
approved drugs that are identical to their brand-name drug counterpart
but are sold without brand-name labeling.

A total of 854 authorized generics launched between 2010 and 2019, with
entry spiking in 2014. The authors find that authorized generics are
introduced "when the threat of generic entry is heightened after the
first traditional generic is approved for the authorized generic's
brand-name drug."

Julia Dennett and Gregg Gonsalves examine the long-term effects of the
initial marketing of OxyContin
<[link removed]>
in 1996.

They find that states with higher levels of exposure to initial
OxyContin marketing had significantly increased rates of fatal synthetic
opioid-related overdose; increased incidence of acute hepatitis A, B,
and C; and increased rates of infective endocarditis-related mortality
compared to states with lower levels of exposure to early OxyContin
marketing.

James Robinson's Policy Insight offers an analysis of industrial
policy opportunities
<[link removed]>
within the three principal sectors of the life sciences. Among other
policies, Robinson advocates for the support of start-ups and the
strengthening of public procurement for pharmaceutical and medical
technologies.

In Perspectives, J. Stephen Morrison and Michaela Simoneau caution that
an industrial policy-based approach to the life sciences requires
heightened geopolitical awareness
<[link removed]>,
significant public funding, and bipartisan support, and Thomas Bollyky
critiques Robinson's global competition lens
<[link removed]>,
arguing that "the US needs an industrial policy for global health."

Read More
<[link removed]>


Hospitals

Congress allocated $178 billion to the Provider Relief Fund (PRF) in
2020, to offer financial support to hospitals and providers during the
COVID-19 pandemic.

Anuj Gangopadhyaya and coauthors assess how these funds were distributed
<[link removed]>
and find both that PRF funding was "appropriately targeted" and that the
most financially vulnerable hospitals received payments.

Mark Meiselbach and colleagues compare hospital prices negotiated in
commercial health insurance
<[link removed]>
and Medicare Advantage (MA) plans by the same insurer.

When considering prices paid in the same hospital for the same services,
they estimate that "commercial prices are, on average, two to three
times higher than MA prices" and that commercial plans at times pay more
than five times what MA plans pay for the same service.

Vivian Ho and coauthors analyze claims data in five states from 2012 and
2019
<[link removed]>
and find that price increases were the primary drivers of increased
emergency department spending in four of the five states examined
(Colorado, North Carolina, Ohio, and Texas), with upcoding playing a
significant but smaller role.

Read More
<[link removed]>


Equity

Rebecca Gourevitch and coauthors report the results of a randomized
controlled trial of a nurse home visiting program
<[link removed]>
for Medicaid-eligible pregnant people in South Carolina.

The authors "found little evidence of statistically significant changes
in health care use, use of guideline based prenatal care, or prenatal
health" and little effect for socially vulnerable or non-Hispanic Black
program participants.

Jun Li and coauthors explore adoption of the standard medical deduction
<[link removed]>
(SMD), designed to reduce administrative barriers to accessing the
Supplemental Nutrition Assistance Program (SNAP), and find that
"reducing administrative barriers through the SMD is likely an effective
tool to increase SNAP participation."

Corwin Rhyan and coauthors conduct a cost-benefit analysis of
Michigan's recently revised Lead and Copper Rule
<[link removed]>,
which "requires water utilities to inventory existing water service
lines by 2025 and replace all lead-containing lines by 2041."

The authors estimate that these policies, in addition to protecting
hundreds of thousands of children, and particularly those who are low
income or children of color, would generate $1.91 billion in net
savings.

Joshua Mak and coauthors calculate the return on investment
<[link removed]>
(ROI) for the introduction of a four-dose malaria vaccine for the period
2021-30 in twenty sub-Saharan African countries.

Using two different models, they estimate ROIs of 0.42 and 2.30,
respectively, indicating that although there is room for improvement,
there is a "modest positive ROI for the integration of malaria vaccines
in pediatric immunization schedules."

Accountable Health Communities

The Center for Medicare and Medicaid Innovation's Accountable Health
Communities (AHC) Model, launched in 2017, connects eligible Medicare
and Medicaid beneficiaries with community services to address
health-related social needs.

Presenting interim findings of an external evaluation, William Parish
and coauthors conclude that beneficiaries
<[link removed]>who
received navigation assistance
<[link removed]>
had lower rates of emergency department visits than those in the control
group, but the effects of receiving navigation assistance on other
outcomes were not statistically significant.

Jeanette Renaud and coauthors assess whether the AHC Model adequately
addresses beneficiaries' health-related social needs
<[link removed]>
through navigator facilitated connections to community service
providers.

After analyzing survey results, the authors find that although the AHC
Model effectively engaged participants, with more than 75 percent of
beneficiaries opting in to receive navigation, "the assistance-track
intervention did not significantly increase the rate of community
service provider connection or the rate of health-related social needs
resolution."

Order The Issue
<[link removed]>


Join Health Affairs Unlimited to access our current and past issue
<[link removed]>,
premium newsletters and virtual events.

 

[link removed]


This month, join us for the following events:

* August 22: Journal Club: Home
<[link removed]>Visits
With A Registered Nurse Did Not Affect Prenatal Care Use Or Pregnancy
Health Among Medicaid Enrollees
<[link removed]>

Health Affairs Branded Post:

Gamechanger: Shifting from Tobacco Control to Ending the Industry's
Influence for Good
<[link removed]>

Sponsored by Truth Initiative
<[link removed]>

[link removed]

A Health Podysssey: Chip Kahn on Value-based Payment Problems
<[link removed]>

Earlier this week, Health Affairs Editor-in-Chief Alan Weil interviewed
Chip Kahn from the Federation of American Hospitals on his recent paper
in which he and co-authors argue that CMS hospital value-based programs
should be refined
<[link removed]>
to reduce health disparities and improve outcomes.

Health Affairs This Week: FDA Comes Under Scrutiny
<[link removed]>

**Health Affairs**' Michael Gerber and Rob Lott discuss the latest
developments at the FDA, including the first oral treatment for
postpartum depression, the Accelerated Approval Program, and the agency
being namechecked on the GOP presidential campaign trail.

 

Advancing Integrated Care For Dual-Eligible Individuals Through
Multisector Plans For Aging
<[link removed]>Narda
Ipakchi et al.

Tying Equity To Reimbursements
<[link removed]>
Robin Pierce et al.

How to Ensure the Quality and Safety of Our Generic Drugs
<[link removed]>
Rosemary Gibson and Arthur Kellermann

Paying for Dementia Care that Improves Patient Outcomes, Supports
Caregivers, and Saves Money
<[link removed]>
David Reuben et al.

'Vaccines for Children' at 30: Lessons in Bipartisanship and Cooperative
Federalism
<[link removed]>
Richard Hughes IV et al.

How States and Health Plans Can Meaningfully Engage Dually Eligible
Individuals in Plan Governance
<[link removed]>
Sarah Triano et al.

The Biotech Industry Reset is a Tipping Point for Health Equity
Investing
<[link removed]>
Squire Servance

Who's Minding the Shop? Preventive Services Access Turns On Arbitrary
Insurance Policies
<[link removed]>
Amy Killelea

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
<[link removed]> at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org <healthaffairs.org>, Health Affairs Today
<[link removed]>, and Health Affairs Sunday
Update <[link removed]>.  

Project HOPE <[link removed]> is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States

Privacy Policy <[link removed]>

To unsubscribe from this email, click here
<[link removed]>.
_________________

Sent to [email protected]

Unsubscribe:
[link removed]

Health Affairs, 1220 19th Street, NW, Suite 800, Washington, DC 20036, United States